Home
Clinical Resources Search
PQI: clonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma

clonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma

Download PQI pdf 0.17MB

Last Updated: January 8, 2024

By: Kashif Ali, MD

About this PQI

This document will discuss the utility of the clonoSEQ assay in patients with multiple myeloma by following patients during their treatment.

More About This PQI

PQI in Action Articles:

ClonoSEQ_MM pdf 1.01MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Hematological Malignancies Minimal Risidual Disease (MRD) Multiple Meloma (MM) clonoSEQ

PQI

Frequently Searched

Supported by

clonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

PQI: Bone Health and the Cancer Patient

PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

PQI in Action: Larotrectinib (Vitrakvi®) Overview

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

S8 Ep 13: Supporting Patients Through Financial Assistance

Readiness Tracker

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

S7 Ep 8: Sickle Cell Disease Insights

PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)

PQI: clonoSEQ® Next Generation Sequencing for Minimum Residual Disease Testing in Chronic Lymphocytic Leukemia

PQI in Action: ClonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma

PQI: Selinexor (Xpovio®) Patient Management

PQI: Ixazomib (Ninlaro®) In the Treatment of Multiple Myeloma

PQI: Isatuximab-irfc (Sarclisa®) Regimens in 1q21 gain/amplification Relapsed/ Refractory Multiple Myeloma

PQI: Isatuximab-irfc (Sarclisa®) In Patients with Relapsed/Refractory Multiple Myeloma